Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The bacterial 50S ribosomal subunit assembly machinery is a complex and highly regulated system responsible for the biogenesis of the large ribosomal subunit in bacteria (Shajani et al., 2011, Annual Review of Biochemistry). This process requires the coordinated folding of 23S and 5S ribosomal RNAs (rRNAs) and the sequential incorporation of approximately 33 ribosomal proteins (Davis & Williamson, 2017, Philosophical Transactions of the Royal Society B). The assembly is facilitated by a diverse group of non-ribosomal assembly factors, including specialized GTPases such as ObgE and EngA, RNA helicases like SrmB and CsdA, and various chaperones that ensure correct RNA-protein interactions (Britton, 2009, Annual Review of Microbiology). Because ribosome biogenesis is essential for bacterial viability, this machinery serves as a critical target for antimicrobial agents (Champney, 2006, Current Opinion in Microbiology). Many traditional antibiotics, such as macrolides and lincosamides, have been shown to inhibit the assembly of the 50S subunit in addition to their well-known role in blocking protein translation in mature ribosomes (Champney, 2001, Antimicrobial Agents and Chemotherapy). These drugs often bind to the 23S rRNA within assembly intermediates, preventing the transition to a functional 50S subunit. Targeting specific assembly factors represents a promising strategy for the development of novel antibiotics designed to overcome existing resistance mechanisms in multi-drug resistant pathogens.
Inhibition of large ribosomal subunit biogenesis by binding to 23S rRNA assembly intermediates or blocking the activity of essential assembly factors (Champney, 2001, Antimicrobial Agents and Chemotherapy).
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bacterial 50S ribosomal subunit assembly machinery (50S assembly machinery).